US Strikes Iranian Oil Tankers, Strait of Hormuz Risk Surges — Energy Stocks and Crude ETFs in the Crosshairs
US military strikes on Iranian crude carriers and Iran's threat of retaliation ignite geopolitical risk premium in oil markets. Energy equities and cr…
Merck and Moderna's mRNA Cancer Vaccine Hits Phase 3 Milestone — What It Means for MRK and MRNA Investors
Merck and Moderna's Phase 3 INTerpath-001 trial met both primary endpoints for melanoma, validating mRNA neoantigen technology and opening multi-billi…
Trade with the conviction of the 1%.
Institutional-grade market intelligence delivered before the opening bell.
2-Year Treasury Yields Hit 15-Month Highs After Blowout Jobs Report — What Rate-Hike Fears Mean for Your Portfolio
Strong August payrolls data sent 2-year Treasury yields to their highest level since January 2025, triggering equity fun…
Royalty Pharma Shares Under Pressure as Novartis' Pelacarsen Phase 3 HORIZON Trial Disappoints
RPRX's royalty stake in pelacarsen suffers as Novartis' Phase 3 cardiovascular outcomes trial misses key endpoints, pres…
Merck and Moderna's mRNA Cancer Vaccine Scores Phase 3 Win — What It Means for MRK and MRNA Investors
The Phase 3 INTerpath-001 trial of Moderna's personalized mRNA cancer vaccine plus Merck's Keytruda met both co-primary …
August Jobs Report Fuels Fed Rate-Hike Speculation: What It Means for Investors
The August jobs report stirs Fed rate-hike speculation, impacting Treasury yields and equity valuations, particularly fo…
SoundHound AI's Acquisition of LivePerson: Implications for the Tech Market
Analyzing SoundHound AI's acquisition of LivePerson and its impact on the conversational AI landscape.
Moderna and Merck's mRNA Cancer Vaccine Trial: A Turning Point for Biotech Investors
The Phase 3 INTerpath-001 trial results could reshape oncology market dynamics for Moderna and Merck, opening new revenu…
Record Diesel Prices Raise Inflation Concerns in North American Markets
Soaring diesel prices driven by geopolitical conflicts are stirring inflation fears across North America, impacting mult…
Merck and Moderna's mRNA Vaccine Triumphs in Melanoma Phase 3 Trials
Merck and Moderna's Phase 3 trial results demonstrate significant advancements in melanoma treatment, impacting stock pe…
Ionis Pharmaceuticals Secures FDA Approval for Groundbreaking Zanvastro Treatment
Ionis Pharmaceuticals' Zanvastro receives FDA approval, marking a significant milestone in the treatment of Alexander di…